ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE
Approaches to preventing recurrent stroke by antithrombocytic therapy are shown to be as diverse as its causes. The diagnosis of cardioembolic stroke in patients with atrial fibrillation should not limit the choice of an antithrombocytic agent to only oral (indirect) anticoagulants (OAC). If OAC can...
Main Authors: | A. V. Fonyakin, L. A. Geraskina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2009-12-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/356 |
Similar Items
-
ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE
by: A. V. Fonyakin
Published: (2009-06-01) -
Ischemic stroke and antithrombotic therapy: key aspects
by: M. Yu. Maksimova, et al.
Published: (2019-12-01) -
The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01) -
Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack
by: A. V. Fonyakin, et al.
Published: (2021-10-01) -
Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)